BECTON, DICKINSON AND COMPANY

147.63 $ +0.94%

Add to a list

Valuation: Becton, Dickinson and Company

Capitalization 40.68B 35.07B 31.96B 30.27B 56.21B 3,888B 57.07B 381B 149B 1,861B 153B 149B 6,473B P/E ratio 2026 *
36.8x
P/E ratio 2027 * 28.2x
Enterprise value 56.63B 48.82B 44.5B 42.14B 78.25B 5,412B 79.45B 530B 207B 2,591B 213B 208B 9,012B EV / Sales 2026 *
2.95x
EV / Sales 2027 * 2.78x
Free-Float
74.05%
Yield 2026 *
2.61%
Yield 2027 * 2.66%
1 day+0.94%
1 week+2.90%
Current month-0.95%
1 month-2.96%
3 months-19.10%
6 months-22.69%
Current year-23.93%
1 week 141.82
Extreme 141.8201
148.88
1 month 141.82
Extreme 141.8201
155.28
Current year 141.82
Extreme 141.8201
213.08
1 year 141.82
Extreme 141.8201
213.08
3 years 141.82
Extreme 141.8201
287.32
5 years 141.82
Extreme 141.8201
287.32
10 years 141.82
Extreme 141.8201
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Change 5d. change 1-year change 3-years change Capi.($)
+0.94%+2.90%-13.86%-39.80% 40.68B
-0.41%+3.48%-33.43%-15.98% 152B
+0.58%+3.22%-2.58%-10.16% 101B
+0.10%-5.41%+45.13%+59.91% 55.13B
+3.57%+6.67%-5.97%+60.71% 53.49B
-0.24%+2.27% - - 31.3B
+0.28%+16.99%-14.68%-38.23% 27.82B
+0.09%+4.47%+53.91%-7.11% 22.35B
-2.51%+2.35%-14.03%+12.19% 22.19B
-1.41%+2.10%-10.88%+7.83% 21.24B
Average +0.08%+6.03%+0.40%+3.26% 52.74B
Weighted average by Cap. +0.27%+4.19%-7.04%+1.38%

Financials

2026 *2027 *
Net sales 19.2B 16.55B 15.09B 14.29B 26.53B 1,835B 26.94B 180B 70.14B 878B 72.05B 70.53B 3,055B 19.71B 16.99B 15.49B 14.66B 27.23B 1,884B 27.65B 184B 72B 902B 73.96B 72.4B 3,136B
Net income 1.12B 970M 884M 837M 1.55B 107B 1.58B 10.52B 4.11B 51.44B 4.22B 4.13B 179B 1.46B 1.26B 1.15B 1.09B 2.02B 140B 2.05B 13.68B 5.34B 66.86B 5.48B 5.37B 233B
Net Debt 15.95B 13.75B 12.54B 11.87B 22.04B 1,525B 22.38B 149B 58.28B 730B 59.87B 58.61B 2,539B 14.02B 12.09B 11.02B 10.43B 19.38B 1,340B 19.67B 131B 51.23B 641B 52.63B 51.52B 2,232B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-05-22 147.63 $ +0.94% 1.29M
26-05-21 146.25 $ -0.48% 1.99M
26-05-20 146.95 $ 0.00% 2.48M
26-05-19 146.95 $ +3.23% 4.22M
26-05-18 142.35 $ -0.78% 3.81M
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
147.63USD
Average target price
183.29USD
Spread / Average Target
+24.15%

Quarterly revenue - Rate of surprise